Aquestive Therapeutics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AQST Nasdaq 2834 www.aquestive.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aquestive Therapeutics, Inc.

Aquestive Therapeutics Inc (AQST) (Q3 2026) Earnings Call Highlights: Revenue Dip Masks Anifilm ... - Nov 6th, 2026 12:05 pm
Aquestive Therapeutics to Present Data at the 2026 ACAAI Annual Meeting - Nov 5th, 2026 5:00 am
Aquestive Therapeutics, Inc. Q3 2026 Earnings Call Summary - Nov 4th, 2026 10:57 am
Aquestive (AQST) Q3 2026 Earnings Call Transcript - Nov 4th, 2026 10:05 am
What Aquestive Therapeutics (AQST) Said on Its Q3 Earnings Call - Nov 4th, 2026 9:14 am
Aquestive Therapeutics (AQST) Reports Q3 Loss, Misses Revenue Estimates - Nov 3rd, 2026 2:15 pm
Aquestive Therapeutics: Q3 Earnings Snapshot - Nov 3rd, 2026 2:14 pm
Aquestive Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update - Nov 3rd, 2026 2:01 pm
Aquestive Therapeutics to Report Third Quarter 2026 Financial Results and Recent Business Highlights on November 3 and Host Conference Call on November 4 at 8:00 a.m. ET - Oct 27th, 2026 5:00 am
Aquestive Therapeutics Announces FDA Acceptance of Anaphylm™ NDA Resubmission and PDUFA Goal Date of March 16, 2027 - Oct 15th, 2026 5:00 am
Eton Pharmaceuticals and Aquestive Therapeutics Announce Exclusive U.S. Licensing Agreement for LIBERVANT® (diazepam) Buccal Film - Oct 14th, 2026 4:50 am
Aquestive Therapeutics Strengthens Board of Directors with Appointment of Richard Daly - Sep 29th, 2026 5:00 am
Aquestive Therapeutics Announces Resubmission of New Drug Application to FDA for Anaphylm™ (dibutepinephrine) Sublingual Film - Sep 17th, 2026 5:00 am
Aquestive Therapeutics (AQST): Second Chance At Anaphylm Comes Into Focus - Sep 7th, 2026 8:07 pm
Aquestive Therapeutics to Participate in Upcoming September Investor Conferences - Sep 1st, 2026 5:00 am
Aquestive (AQST) Q2 2026 Earnings Call Transcript - Aug 18th, 2026 5:31 pm
Aquestive Therapeutics Inc (AQST) (Q2 2026) Earnings Call Highlights: Anaphylm Resubmission on ... - Aug 12th, 2026 5:04 pm
Aquestive Therapeutics Q2 Earnings Call Highlights - Aug 12th, 2026 8:05 am
Aquestive Therapeutics, Inc. Q2 2026 Earnings Call Summary - Aug 12th, 2026 6:30 am